Alcohol Use Disorder (AUD)
92
33
39
24
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Published Results
11 trials with published results (12%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
3.3%
3 terminated out of 92 trials
88.9%
+2.4% vs benchmark
3%
3 trials in Phase 3/4
46%
11 of 24 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 24 completed trials
Clinical Trials (92)
Brain Inflammation and Function in Alcoholism
A Study to Investigate the Safety and Efficacy of TMP-301 Compared to Placebo in Adult Patients With Alcohol Use Disorder
Deaf CBT-TS to Reduce Suicide Risk
MPFC Theta Burst Stimulation as a Treatment Tool for Alcohol Use Disorder: Effects on Drinking and Incentive Salience
OEA for Young Adults With Alcohol Use Disorder
Relationship Between Brain and Heart Glucose Metabolism in Alcohol Use Disorder
Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and Craving
Metabolome and Gut Microbiome Changes During Smoking Cessation in Long-term Drug Therapy in a Therapeutic Community
Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide
Imaging Phosphodiesterase 4B (PDE4B) in People With Psychiatric Disorders With Positron Emission Tomography (PET) and the Radiotracer [18F]PF974
Alpha-1 Blockade for Alcohol Use Disorder (AUD)
Probenecid Administration for Alcohol Craving and Consumption
Social Identity Mapping for Adolescent Recovery
LHC-CIDI-5 in Hong Kong
Acceptability and Feasibility Study of Non-alcoholic Beverages
Evaluate the Efficacy and Safety of Naltrexone Hydrochloride Implant in Patients With Alcohol Use Disorder
Web-based Alcohol- or Cocaine-specific Inhibition Training in Adolescents and Young Adults With Substance Use Disorder
Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder
Brain Network Modulation and Alcohol Use
Diclofenac Dose Response Study